Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 1 , Pages 72-75 , January 2008

Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job’s syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin

References 

  1. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692
  2. Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000;11:133
  3. Shemer A, Weiss G, Confino Y, Trau H. The hyper-IgE syndrome: two cases and review of the literature. Int J Dermatol. 2001;40:622
  4. Garraud O, Mollis SN, Holland SM, Sneller MC, Malech HL, Gallin JI, et al. Regulation of immunoglobulin production in hyper-IgE (Job’s) syndrome. J Allergy Clin Immunol. 1999;103:333
  5. DeWitt A, Bishop L, Buescher LS, Stone SP. Hyperimmunoglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol. 2006;54:855–865
  6. Davis SD, Schaller S, Wedgwood RJ. Job’s syndrome: recurrent “cold” staphylococcal abscesses. Lancet. 1966;1:1013–1015
  7. Chambers HF, Korzeniowski OM, Sande MA, et al. Staphylococcus aureus endocarditis: Clinical manifestations in addicts and nonaddicts. Medicine (Baltimore). 1983;62:170
  8. Julander I. Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis. Scand J Infect Dis. 1985;17:179–187
  9. Thompson RL. Staphylococcal infective endocarditis. Mayo Clin Proc. 1982;57:106
  10. Bayer AS. Staphylococcal bacteremia and endocarditis: state of the art. Arch Intern Med. 1982;142:1169
  11. Sanabria TJ, Alpert JS, Goldberg R, et al. Increasing frequency of staphylococcal infective endocarditis: experience at a university hospital, 1981 through 1988. Arch Intern Med. 1990;150:1305–1309
  12. Fowler VG, Sanders LL, Kong L, et al. Staphylococcus aureus endocarditis: 59 prospectively identified cases with followup. Clin Infect Dis. 1999;28:106–114
  13. Sklaver AR, Hoffman TA, Greenman RL. Staphylococcal endocarditis in addicts. South Med J. 1978;71:638
  14. Thadepalli H, Francis CK. Diagnostic clues in metastatic lesions of endocarditis in addicts. West J Med. 1978;128:1
  15. Miro JM, Anguera I, Cabell CH, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis. 2005;41:507–514
  16. Cunha BA. Antibiotic Essentials. (6th ed). Royal Oaks, MI: Physician’s Press; 2007;
  17. Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653–665
  18. Cunha BA, Hamid HS, Kessler H, Parchuri S. Daptomycin cure after cefazolin treatment failure of Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis (ABE) from a peripherally inserted central catheter (PICC) line. Heart Lung. 2005;34:442–447
  19. Mohan S, McDermott BP, Cunha BA. Methicillin-resistant Staphylococcus aureus (MRSA) prosthetic valve endocarditis (PVE) with paravalvular abscess treated with daptomycin. Heart Lung. 2005;34:69–71
  20. Cunha BA, Eisenstein LE, Hamid N. Pacemaker induced S. aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from an infection coronary stent: cure with a prolonged/high dose daptomycin without toxicity. Heart Lung. 2006;35:217–222
  21. Cunha BA. Persistent S. aureus bacteremia: a clinical approach. Infect Dis Pract. 2005;29:444–446
  22. Cunha BA. Persistent S. aureus bacteremia: clinical pathways for diagnosis and treatment. Antibiotics Clin. 2006;10(S1):39–46
  23. Cunha BA. MSSA/MRSA acute bacterial endocarditis (ABE) clinical pathway for diagnosis and treatment. Antibiotics Clin. 2006;10(S1):29–34
  24. Cunha BA. Oral antibiotics to treat MRSA infections. J Hosp Infect. 2005;60:88–90
  25. Cunha BA. Clinical manifestations and antimicrobial therapy of methicillin resistant Staphylococcus aureus (MRSA). Clin Microbiol Infect. 2005;11:33–42
  26. Cunha BA. Antimicrobial therapy of multi-drug resistant S. pneumoniae VRE and MRSA. Med Clin North Am. 2006;90:1165–1182

PII: S0147-9563(07)00083-0

doi: 10.1016/j.hrtlng.2007.04.003

Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 1 , Pages 72-75 , January 2008